Rani Therapeutics (RANI) Appoints Lyn Baranowski to its Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Rani Therapeutics Appoints Lyn Baranowski to Board of Directors
November 12, 2021 4:05 PM ESTSAN JOSE, Calif., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (Rani Therapeutics or Rani) (Nasdaq: RANI), a clinical stage biotherapeutics company focused on advancing technologies to enable the development of orally administered biologics, today announced the appointment of Lyn Baranowski to its Board of Directors. Ms. Baranowski is a distinguished biotechnology executive with nearly two decades of experience.
Lyn is a well-respected biotechnology executive whose deep experience includes a diverse set of product portfolios and therapeutic areas, said Talat Imran, Chief Executive Officer of Rani Therapeutics. Lyns track record in creating strategic... More
